Faulty BRCA2 gene may indicate higher cancer risk in men, too
Typically, when we hear about faulty BRCA2 genes, we associate them with breast cancer among women. However, new research shows that men are also impacted, and those who have faulty BRCA2 genes are five times more likely to be diagnosed with prostate cancer at a younger age. This high-risk group is also twice as likely to have a more serious, potentially life-threatening, form of prostate cancer.
The BRCA2 gene plays an important role in repairing breaks in our DNA. When the gene is faulty, this process doesn’t occur properly, resulting in mutations that can lead to cancer. According to the research, people who are at risk have a range of options available to them. In many cases, getting more regular PSA testing – a blood test to screen for prostate cancer – may be enough. Learn more about the research findings at ScienceAlert.